Non-small-cell lung cancer (NSCLC) is a very common disease in the elderly population
and its incidence in this particular population is expected to increase further, because of the …

Pulmonary disease prevalence increases with age and contributes to morbidity and mortality
in older patients. Dyspnea in older patients is often ascribed to multiple etiologies such as …

A major challenge affecting the outcomes of patients with lung cancer is the development of
acquired radioresistance. However, the mechanisms underlying the development of …

Rationale: Bak is a major proapoptotic Bcl2 family member and a required molecule for
apoptotic cell death. High levels of endogenous Bak were observed in both small cell lung …

Bcl-XL is a major antiapoptotic protein in the Bcl-2 family whose overexpression is more
widely observed in human lung cancer cells than that of Bcl-2, suggesting that Bcl-XL is …

Background Concurrent chemoradiation with etoposide and cisplatin (EP/XRT) is standard
treatment for inoperable stage III locally advanced non-small-cell lung cancer (LA-NSCLC) …

Introduction: Lung cancer is the leading cause of cancer mortality worldwide. We analyzed
changes in treatment and their potential effect on survival of non-small cell lung cancer …

OBJECTIVES Older lung cancer patients with multiple morbidities are increasingly referred
to thoracic surgery departments. The aim of this multicenter study was to analyse the …

Aim: The objective of this study is to investigate prognostic factors affecting survival of
patients undergoing concurrent or sequential chemoradiotherapy (CRT) for stage III non …

Background Wide variation exists globally in the treatment and outcomes of stage III patients
with non–small cell lung cancer (NSCLC). We conducted an up-to-date patterns of care …